Review Article

Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence

Table 7

Current state of evidence for the effects of omega-3 PUFA in published human studies regarding prostate cancer.

Type of studyBeneficial effectBeneficial effect limited to subpopulationsDetrimental effect limited to subpopulationsNo or detrimental effects

Observational studiesInverse association between fish consumption and cancer incidence [103]Dietary omega-3/omega-6 PUFA ratio inversely associated with risk of high-grade cancer [104]Positive association between EPA and risk of only high-grade cancer [105]Dietary omega-3/omega-6 PUFA ratio not associated with risk of low-grade cancer [104]
Inverse association between high intake and risk of aggressive cancer [106]Positive association between high serum PL LC-omega-3 PUFA and cancer risk [25]No association between fish or FO intake and cancer risk [107]
Inverse association between higher fish intake and risk of cancer death [108]No association between erythrocyte membrane EPA, DPA, or DHA and total or advanced/high-grade cancer risk [109]
Inverse association between FO intake and risk of advanced cancer later life [110]No association between serum EPA or DHA and cancer risk in male smokers [111]
Inverse association between DPA level and total risk of cancer [112, 113]No association between omega-3 PUFA intake and PSA level [114]
Positive association between EPA or DHA and high-grade cancer [112, 113]
No association between DHA level and risk of cancer at any stages [105]
No association between total serum PL omega-3 PUFA and cancer risk [115]

Meta-analysesInverse association between fish intake and prostate cancer-specific mortality [116]No association between FO intake or EPA/DHA blood level and cancer risk [117]

FO: fish oil; PL: phospholipids; PSA: prostate-specific antigen.